| Date | Time | Source | Headline | Symbol | Company |
| 05/15/2014 | 4:10PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CGIX | Cancer Genetics Inc |
| 05/15/2014 | 8:15AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Announces Acquisition of Premier Genomics and Next Generation Sequencing Company, BioServe India | NASDAQ:CGIX | Cancer Genetics Inc |
| 05/15/2014 | 8:12AM | GlobeNewswire Inc. | Cancer Genetics Enters Into Agreement to Acquire BioServe India, a Premier Genomics & Next Generation Sequencing Company, and... | NASDAQ:CGIX | Cancer Genetics Inc |
| 05/14/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics, Inc. to Present at the UBS Global Healthcare Conference | NASDAQ:CGIX | Cancer Genetics Inc |
| 05/08/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics to Report First Quarter 2014 Results on Thursday, May 15, 2014 | NASDAQ:CGIX | Cancer Genetics Inc |
| 05/05/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics Launches Genomic Tests for Follicular Lymphoma and Mantle Cell Lymphoma - Further Extends Unique Position in ... | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/25/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics to Promote FHACT(TM) Test for Cervical Cancer at American Congress of Obstetricians and Gynecologists' Annual... | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/21/2014 | 10:23AM | GlobeNewswire Inc. | 30+ Leading Small-Cap Companies to Present at RedChip Global Online CEO Conference, April 23-24 | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/21/2014 | 9:01AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/10/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics CEO Moderates Panel Discussion With Thought Leaders in Biopharma at the BioNJ 2014 International BioPartnerin... | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/04/2014 | 4:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/04/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferativ... | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/03/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics to Present New Data From Renal Cell Carcinoma Study at AACR | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/01/2014 | 1:49PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CGIX | Cancer Genetics Inc |
| 04/01/2014 | 9:00AM | Marketwired | LifeSci Advisors Initiates Coverage of Cancer Genetics, Inc. | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/28/2014 | 5:02PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/27/2014 | 10:56AM | GlobeNewswire Inc. | RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/26/2014 | 4:01PM | GlobeNewswire Inc. | Cancer Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Results, Provides Corporate Update | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/21/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics to Report Fourth Quarter and Year-End 2013 Results on Wednesday, March 26, 2014 | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/20/2014 | 8:00AM | GlobeNewswire Inc. | CGI's Proprietary DNA-Based Test for Cervical Cancer, FHACT(TM), Adopted by Leading Kamineni Hospital Group in India for the ... | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/17/2014 | 8:00AM | GlobeNewswire Inc. | Cancer Genetics Appoints Edward J. Sitar as Chief Financial Officer | NASDAQ:CGIX | Cancer Genetics Inc |
| 03/05/2014 | 8:01AM | GlobeNewswire Inc. | Cancer Genetics Announces Compelling Diagnostic Sensitivity (99%) and Accuracy (93%) for Its Patent-Protected Genomic Kidney ... | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/26/2014 | 7:30AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Adds Additional Kidney Cancer Patent to its Portfolio | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/24/2014 | 7:30AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Announces a New Breakthrough for Diagnosis and Prediction of Kidney Cancer Outcomes Using Its Proprieta... | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/21/2014 | 4:17PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/20/2014 | 7:50AM | GlobeNewswire Inc. | Cancer Genetics, Inc. New Clinical Trial Backlog Exceeds $13 Million | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/18/2014 | 7:00AM | GlobeNewswire Inc. | Cancer Genetics is Pleased to Announce the Appointment of Dr. Paul Rothman, Dean of the Medical Faculty and CEO of Johns Hopk... | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/10/2014 | 4:01PM | GlobeNewswire Inc. | Cancer Genetics to Provide Corporate Update at 16th Annual BIO CEO & Investor Conference in New York | NASDAQ:CGIX | Cancer Genetics Inc |
| 02/10/2014 | 7:00AM | GlobeNewswire Inc. | Cancer Genetics, Inc. and Roche Announce Expanded, Exclusive International Agreement to Provide Molecular Diagnostic Cancer T... | NASDAQ:CGIX | Cancer Genetics Inc |
| 01/29/2014 | 7:20AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Launches Webinar Series to Drive Awareness and Adoption of Its Proprietary DNA-Based Cervical Cancer Di... | NASDAQ:CGIX | Cancer Genetics Inc |